232 related articles for article (PubMed ID: 38731942)
41. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
[TBL] [Abstract][Full Text] [Related]
42. Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras.
Asahina K; Balog S; Hwang E; Moon E; Wan E; Skrypek K; Chen Y; Fernandez J; Romo J; Yang Q; Lai K; French SW; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G265-G276. PubMed ID: 31760766
[No Abstract] [Full Text] [Related]
43. Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer.
Wong CH; Li YJ; Chen YC
World J Gastroenterol; 2016 Aug; 22(31):7046-57. PubMed ID: 27610015
[TBL] [Abstract][Full Text] [Related]
44. Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia.
Ebine K; Chow CR; DeCant BT; Hattaway HZ; Grippo PJ; Kumar K; Munshi HG
Sci Rep; 2016 Jul; 6():29133. PubMed ID: 27364947
[TBL] [Abstract][Full Text] [Related]
45. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.
Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ
Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173
[TBL] [Abstract][Full Text] [Related]
46. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
Zhang S; Chung WC; Xu K
Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
[TBL] [Abstract][Full Text] [Related]
47. ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis.
Wang L; Yang H; Zamperone A; Diolaiti D; Palmbos PL; Abel EV; Purohit V; Dolgalev I; Rhim AD; Ljungman M; Hadju CH; Halbrook CJ; Bar-Sagi D; di Magliano MP; Crawford HC; Simeone DM
Genes Dev; 2019 Jun; 33(11-12):641-655. PubMed ID: 31048544
[TBL] [Abstract][Full Text] [Related]
48. Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
Niu N; Lu P; Yang Y; He R; Zhang L; Shi J; Wu J; Yang M; Zhang ZG; Wang LW; Gao WQ; Habtezion A; Xiao GG; Sun Y; Li L; Xue J
Gut; 2020 Apr; 69(4):715-726. PubMed ID: 31300513
[TBL] [Abstract][Full Text] [Related]
49. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer.
Wauters E; Sanchez-Arévalo Lobo VJ; Pinho AV; Mawson A; Herranz D; Wu J; Cowley MJ; Colvin EK; Njicop EN; Sutherland RL; Liu T; Serrano M; Bouwens L; Real FX; Biankin AV; Rooman I
Cancer Res; 2013 Apr; 73(7):2357-67. PubMed ID: 23370328
[TBL] [Abstract][Full Text] [Related]
50. Differential impact of the ERBB receptors EGFR and ERBB2 on the initiation of precursor lesions of pancreatic ductal adenocarcinoma.
Meyers N; Gérard C; Lemaigre FP; Jacquemin P
Sci Rep; 2020 Mar; 10(1):5241. PubMed ID: 32251323
[TBL] [Abstract][Full Text] [Related]
51. Protein kinase C iota regulates pancreatic acinar-to-ductal metaplasia.
Scotti ML; Smith KE; Butler AM; Calcagno SR; Crawford HC; Leitges M; Fields AP; Murray NR
PLoS One; 2012; 7(2):e30509. PubMed ID: 22359542
[TBL] [Abstract][Full Text] [Related]
52. κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis.
Beel S; Kolloch L; Apken LH; Jürgens L; Bolle A; Sudhof N; Ghosh S; Wardelmann E; Meisterernst M; Steinestel K; Oeckinghaus A
Nat Commun; 2020 Jul; 11(1):3409. PubMed ID: 32641778
[TBL] [Abstract][Full Text] [Related]
53. PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice.
Wu CY; Carpenter ES; Takeuchi KK; Halbrook CJ; Peverley LV; Bien H; Hall JC; DelGiorno KE; Pal D; Song Y; Shi C; Lin RZ; Crawford HC
Gastroenterology; 2014 Dec; 147(6):1405-16.e7. PubMed ID: 25311989
[TBL] [Abstract][Full Text] [Related]
54. KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy.
Gurreri E; Genovese G; Perelli L; Agostini A; Piro G; Carbone C; Tortora G
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298264
[TBL] [Abstract][Full Text] [Related]
55. Oxidative stress induced by inactivation of TP53INP1 cooperates with KrasG12D to initiate and promote pancreatic carcinogenesis in the murine pancreas.
Al Saati T; Clerc P; Hanoun N; Peuget S; Lulka H; Gigoux V; Capilla F; Béluchon B; Couvelard A; Selves J; Buscail L; Carrier A; Dusetti N; Dufresne M
Am J Pathol; 2013 Jun; 182(6):1996-2004. PubMed ID: 23578383
[TBL] [Abstract][Full Text] [Related]
56. Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia.
Pitarresi JR; Liu X; Sharma SM; Cuitiño MC; Kladney RD; Mace TA; Donohue S; Nayak SG; Qu C; Lee J; Woelke SA; Trela S; LaPak K; Yu L; McElroy J; Rosol TJ; Shakya R; Ludwig T; Lesinski GB; Fernandez SA; Konieczny SF; Leone G; Wu J; Ostrowski MC
Neoplasia; 2016 Sep; 18(9):541-52. PubMed ID: 27659014
[TBL] [Abstract][Full Text] [Related]
57. Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer.
Azizi N; Toma J; Martin M; Khalid MF; Mousavi F; Win PW; Borrello MT; Steele N; Shi J; di Magliano MP; Pin CL
Oncogene; 2021 Apr; 40(17):3118-3135. PubMed ID: 33864001
[TBL] [Abstract][Full Text] [Related]
58. Multifaceted role for p53 in pancreatic cancer suppression.
Mello SS; Flowers BM; Mazur PK; Lee JJ; Müller F; Denny SK; Ferreira S; Hanson K; Kim SK; Greenleaf WJ; Wood LD; Attardi LD
Proc Natl Acad Sci U S A; 2023 Mar; 120(10):e2211937120. PubMed ID: 36848578
[TBL] [Abstract][Full Text] [Related]
59. Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model.
Mallya K; Haridas D; Seshacharyulu P; Pothuraju R; Junker WM; Krishn SR; Muniyan S; Vengoji R; Batra SK; Rachagani S
Biol Open; 2020 Sep; 9(9):. PubMed ID: 32709695
[TBL] [Abstract][Full Text] [Related]
60. KRAS(G12D)- and BRAF(V600E)-induced transformation of murine pancreatic epithelial cells requires MEK/ERK-stimulated IGF1R signaling.
Appleman VA; Ahronian LG; Cai J; Klimstra DS; Lewis BC
Mol Cancer Res; 2012 Sep; 10(9):1228-39. PubMed ID: 22871572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
